http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103933046-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate | 2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103933046-B |
| titleOfInvention | A kind of anti-pancreatic cancer medicament composition and its application, medicine box and package |
| abstract | The invention belongs to biomedicine technical field, it is related to a kind of anti-pancreatic cancer pharmaceutical composition and application, medicine box and package.Described pharmaceutical composition, medicine box and package contain the epidermal growth factor tyrosine kinase inhibitor Tarceva for the amiloride and therapeutically effective amount of the therapeutically effective amount simultaneously, separately or sequentially used as combination formulations, wherein, the molar ratio of amiloride and Tarceva is 500:1~1:50.Pharmaceutical composition, medicine box and the package of the present invention is for that when treating tumour, can obtain the drug effect being used alone better than Tarceva, improve the effect of clinical chemotherapy. |
| priorityDate | 2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.